Our LNA Gapmer Synthesis services support biotechnology companies, pharmaceutical research teams, CROs, academic laboratories, and functional genomics groups that require custom antisense oligonucleotides for RNase H-dependent RNA knockdown studies. LNA gapmers combine a central DNA region capable of supporting RNase H activity with locked nucleic acid-modified flanking regions that increase target-binding affinity and help stabilize the oligonucleotide. This architecture makes LNA gapmers useful when researchers need potent sequence-specific suppression of mRNA, lncRNA, nuclear RNA, or other accessible RNA targets.
Successful LNA gapmer projects depend on more than synthesis of the requested sequence. Target-site accessibility, transcript isoforms, LNA placement, DNA gap architecture, phosphorothioate backbone design, sequence-dependent off-target potential, purification, and analytical confirmation can all influence experimental performance. Our service integrates design review, custom LNA/DNA synthesis, backbone engineering, purification, quality analysis, candidate-panel preparation, and optional modification or conjugation support to provide research teams with application-ready LNA gapmers and clearly defined sequence specifications.
Target Site Selection: A theoretically complementary sequence is not necessarily an effective gapmer target. Transcript structure, isoform selection, neighboring sequence composition, competing RNA interactions, and target accessibility can influence hybridization and RNase H-mediated cleavage. We review the intended transcript and candidate binding regions before chemistry is finalized.
RNase H-Compatible Architecture: LNA modifications increase duplex stability, but the central region must retain sufficient DNA character for productive RNase H recognition. We assess wing placement, DNA gap architecture, oligonucleotide length, and modification distribution so that affinity-enhancing chemistry does not compromise the intended cleavage mechanism.
Affinity Versus Selectivity: Increasing LNA content can strengthen RNA binding, but excessive affinity may also increase hybridization to partially matched sequences or create unfavorable self-interactions. Candidate design therefore requires a balance between target affinity, sequence discrimination, secondary structure, and transcriptome-level specificity rather than simply maximizing LNA content.
Backbone and Purification Complexity: Phosphorothioate linkages are commonly incorporated into gapmer designs to improve nuclease resistance, but heavily modified LNA/DNA oligonucleotides can present synthesis and chromatographic challenges. We align synthesis conditions, backbone configuration, purification strategy, and analytical methods with the sequence and modification pattern.
Candidate-to-Candidate Variability: Computational design can reduce poor candidates, but it cannot fully predict intracellular target accessibility or sequence-specific behavior. For important knockdown programs, preparing several independently targeted gapmers provides a more informative screening strategy than relying on a single sequence. Candidate panels can be designed and synthesized under aligned chemistry and QC conditions for more meaningful comparison.
Our LNA gapmer synthesis platform supports both customer-defined sequences and projects requiring design input. Service scope can be configured around target selection, LNA/DNA architecture, phosphorothioate backbone placement, synthesis scale, purification requirements, analytical characterization, candidate screening, and downstream functionalization.
Projects can also be integrated with broader custom antisense oligonucleotide synthesis and gapmer oligonucleotide synthesis workflows when comparative chemistries or multiple ASO formats are required.
LNA gapmer architecture should be selected around the target RNA, intended mechanism, experimental system, and analytical requirements. The following configuration matrix highlights the major variables that should be defined before synthesis rather than treated as fixed design rules.
| Design Element | Configuration Options | Functional Role | Key Selection Factors | Project Output |
| Target Sequence | Single site, multiple sites, transcript-specific, or isoform-aware designs | Defines RNA recognition and the position of RNase H-dependent cleavage | Transcript identity, sequence accessibility, homology, GC pattern, secondary structure | Approved antisense sequence and target annotation |
| LNA Wings | Symmetric or asymmetric LNA placement at the 5' and 3' regions | Increases duplex stability and contributes to nuclease resistance and target affinity | Required affinity, sequence composition, mismatch risk, self-complementarity | Defined LNA position map |
| DNA Gap | Project-specific central DNA region between modified wings | Creates the DNA/RNA duplex region required for RNase H recognition | Gap length, neighboring LNA residues, target sequence, desired cleavage behavior | RNase H-compatible gap architecture |
| Backbone | Phosphorothioate, phosphodiester, or selected mixed patterns where appropriate | Influences nuclease stability, handling, molecular interactions, and analytical behavior | Experimental environment, stability requirements, synthesis complexity, purification strategy | Internucleotide linkage specification |
| Terminal Chemistry | Unmodified termini, functional groups, labels, spacers, or conjugation handles | Enables detection, immobilization, tracking, or downstream conjugation | Assay format, attachment site, steric effects, linker compatibility | Modification and linker specification |
| Supply Format | Individual tubes, aliquots, or plate-oriented candidate sets | Supports efficient screening, repeat experiments, and project handoff | Candidate number, experimental concentration, storage plan, workflow automation | Research-ready material in the agreed format |
Modified gapmers require analytical planning that reflects their sequence, LNA content, backbone chemistry, and intended use. Rather than applying the same analytical package to every construct, testing can be selected to answer the identity, purity, content, and handling questions that are most relevant to the project.
| Review Category | Purpose | Typical Approach | Key Risk Addressed | Decision Supported |
| Sequence & Modification Review | Confirm that the intended LNA/DNA architecture is correctly defined before synthesis | Sequence map, LNA position review, DNA gap verification, backbone specification | Incorrect monomer placement or incompatible architecture | Final design approval |
| Identity Confirmation | Confirm that the synthesized material is consistent with the expected molecular composition | Mass spectrometric analysis according to construct requirements | Incorrect sequence, incomplete synthesis, or unexpected modification state | Material identity assessment |
| Purity Assessment | Evaluate the proportion of full-length product relative to synthesis-related species | Appropriate chromatographic or complementary analytical methods | Truncated products and synthesis-related impurities | Suitability for downstream research |
| Backbone Review | Check chemistry associated with phosphorothioate or mixed-backbone configurations | Process review and analytical assessment selected for the requested linkage pattern | Incomplete or inconsistent backbone modification | Chemistry consistency |
| Content Assessment | Provide material information needed for experimental dosing or solution preparation | Concentration, absorbance-based measurement, or project-specific content determination | Inaccurate experimental concentration | Experimental setup |
| Handling Review | Reduce avoidable variability after material delivery | Solvent, concentration, aliquoting, storage, and freeze-thaw planning | Poor solubilization or repeated handling effects | Sample preparation strategy |
| Candidate Comparison | Maintain comparable material quality across screening panels | Aligned synthesis, purification, analytical, and normalization workflows | Chemistry-related variability being mistaken for sequence effects | Candidate prioritization |
Our workflow connects biological target definition with oligonucleotide chemistry so that sequence design, synthesis, purification, and analytical review are planned as one coordinated project. Individual steps can be adjusted when customers provide an established sequence or require only selected synthesis services.
Define the target RNA, transcript accession or sequence, intended knockdown objective, experimental system, candidate number, modification preferences, and required material format. This establishes whether the project requires design support, direct synthesis, a screening panel, or comparative gapmer chemistries.
Evaluate target regions, sequence uniqueness, self-complementarity, LNA placement, DNA gap configuration, and backbone requirements. Multiple candidates can be prioritized when target accessibility or sequence-specific activity cannot be resolved confidently from sequence analysis alone.
Finalize LNA and DNA positions, internucleotide linkage pattern, terminal groups, optional labels or conjugation handles, purification level, analytical package, quantity, and packaging format before synthesis begins.
Execute solid-phase oligonucleotide synthesis using the approved monomer and backbone configuration, followed by cleavage, deprotection, and a purification workflow selected for the sequence complexity and requested research application.
Complete the agreed identity, purity, and material assessments before preparing the oligonucleotide in the requested tube, aliquot, or plate-oriented format. Candidate panels can be normalized to simplify downstream comparative screening.
Provide the synthesized LNA gapmer together with the agreed sequence specifications and analytical information. Follow-on discussions can address candidate expansion, alternative gap architectures, larger research quantities, conjugation, or additional characterization.
LNA gapmer performance is determined jointly by biological sequence selection and chemical architecture. Our service is structured to help research teams control both sides of that problem while keeping synthesis specifications, analytical expectations, and follow-on screening requirements clearly defined.
LNA gapmers are particularly useful in research workflows that require sequence-specific RNA reduction through an RNase H-dependent antisense mechanism. The chemistry can be adapted for different transcript classes, candidate-screening strategies, and functional genomics questions.
Whether you already have a defined LNA gapmer sequence or need support selecting target regions and modification architecture, our team can help organize the project from sequence review through synthesis, purification, and analytical characterization. We support individual gapmers, multi-candidate screening sets, modified constructs, and follow-on research supply with project specifications tailored to the RNA target and experimental workflow. Contact us to discuss your target sequence, preferred gapmer architecture, required quantity, purification needs, and analytical expectations.
LNA Gapmers offer significantly higher binding affinity, improved target specificity, and enhanced nuclease resistance, making them ideal for detecting low-abundance targets.
Our design strategy carefully balances LNA content and positioning to maximize target affinity while minimizing self-complementarity and secondary structure formation.
Yes, we specialize in custom optimization of LNA content, sequence length, and modification patterns to address difficult targets including those with complex secondary structures.
Loading ......
